Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Lori, Berard"'
Autor:
Michael Vallis, Hana Ryan, Lori Berard, Emmanuel Cosson, Finn Boerlum Kristensen, Fleur Levrat-Guillen, Nicolas Naiditch, Remi Rabasa-Lhoret, William Polonsky
Publikováno v:
Canadian Journal of Diabetes.
Publikováno v:
Diabetes Therapy
In recent years, the development of basal insulin therapies has focused on insulin analogues that have longer durations of action and more predictable pharmacokinetic/pharmacodynamic (PK/PD) profiles than their human insulin-based predecessors, such
Publikováno v:
Diabetes Therapy
Diabetes Therapy, 2020, 11 (4), pp.1007-1015. ⟨10.1007/s13300-020-00797-y⟩
Diabetes Therapy, 2020, 11 (4), pp.1007-1015. ⟨10.1007/s13300-020-00797-y⟩
Introduction With longer duration and progression of type 2 diabetes (T2D), β-cell function deteriorates and insulin therapy often becomes necessary. Glucagon-like peptide-1 receptor agonists such as lixisenatide that do not rely only on β-cell fun
Publikováno v:
Diabetes, Obesity & Metabolism
Achieving target glycaemic control is essential in people with diabetes to minimize the risk of long‐term complications, and many people with type 2 diabetes will ultimately require basal insulin (BI) therapy to achieve their individualized glycaem
Publikováno v:
ClinicoEconomics and outcomes research : CEOR. 14
Evidence demonstrates that glucose-sensing technologies have enabled effective glycemic control for adults and children with type 1 diabetes (T1DM) or adults with type 2 diabetes (T2DM) on insulin therapy or non-insulin therapy. Here, we report on th
Autor:
Lori Berard, Leah Baccari, Teresa Oliveria, Edward T. Mahoney, Katharine D. Barnard-Kelly, Stanislav Glezer, Didier Morel
Publikováno v:
Diabetes spectrum : a publication of the American Diabetes Association. 34(2)
OBJECTIVE Approximately 200 million people worldwide use injectable therapies as part of diabetes management. There appears to be a significant gap between insulin injection technique recommendations and injection practice for many. We aimed to devel
Autor:
Grégory Bigot, Zsolt Bosnyak, Lori Berard, Emma G. Wilmot, Luis Eduardo Calliari, Daniela Bruttomesso, F. Javier Ampudia-Blasco, Anne L. Peters, Jochen Seufert, Dubravka Jurišić-Eržen, Eric Renard, Aude Roborel de Climens, Kelly L. Close
Publikováno v:
Diabetes, Obesity and Metabolism
Diabetes, Obesity and Metabolism, Wiley, 2021, 23 (8), pp.1892-1901. ⟨10.1111/dom.14416⟩
Diabetes, Obesity and Metabolism, 2021, 23 (8), pp.1892-1901. ⟨10.1111/dom.14416⟩
Diabetes, Obesity and Metabolism, Wiley, 2021, 23 (8), pp.1892-1901. ⟨10.1111/dom.14416⟩
Diabetes, Obesity and Metabolism, 2021, 23 (8), pp.1892-1901. ⟨10.1111/dom.14416⟩
International audience; Aims: This secondary analysis of the SAGE study aimed to evaluate the association between glycaemic control and patient-reported outcomes (PROs), in adults with type 1 diabetes (T1DM) across different age groups and regions.Ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1763bf708cc1f8afe57783b01384ef3f
https://hal.archives-ouvertes.fr/hal-03218691
https://hal.archives-ouvertes.fr/hal-03218691
Autor:
Lori Berard, Yao Huang, Vanita R. Aroda, Aramesh Saremi, Jochen Seufert, Lawrence Blonde, Denis Raccah
Publikováno v:
Präzisionsmedizin – Eine Reise in die Zukunft der Diabetologie www.diabeteskongress.de.
Autor:
Natalia, McInnes, Stephanie, Hall, Irene, Hramiak, Ronald J, Sigal, Ronald, Goldenberg, Nikhil, Gupta, Remi, Rabasa-Lhoret, Manoela, Braga, Vincent, Woo, Farah, Sultan, Rose, Otto, Ada, Smith, Diana, Sherifali, Yan Yun, Liu, Hertzel C, Gerstein, Stephanie, Blanchard, Nikki, Pinder, Yan, Yun Liu, Terri, Paul, Tisha, Joy, Margaret, Watson, Marsha, Driscoll, Ronald, Sigal, Sonia, Butalia, Brittany, Rossiter, Michelle, Smith, Victoria, Tully, Robert, Schlosser, David, Sionit, Tanvi, Talsania, Jennifer, Huynh, Sarah, Birch, Sukaina, Davdani, Danijela, Bovan, Marie, Raffray, Tracy, Tazzeo, Kelly, Scott, Katie, Hiltz Mackenzie, Lori, Berard, Claudia, Mandock, Theresa, Anderlic
Publikováno v:
Diabetes care. 45(1)
OBJECTIVE The aim of the study was to evaluate remission of type 2 diabetes following a short-term intervention with insulin glargine, sitagliptin/metformin, and lifestyle approaches. RESEARCH DESIGN AND METHODS In this open multicenter trial, 102 pa
Oral glucagon-like peptide-receptor agonists (GLP1RA) counseling: comparison with insulin counseling
Publikováno v:
Postgraduate medicine. 132(8)
The diabetes management landscape is experiencing significant innovation in care, which is welcomed by the patients and health-care professionals across the globe. Novel class of glucose-lowering m...